These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2254493)

  • 1. Topical corticosteroid compounding.
    Oriba HA; Bucks DA
    J Am Acad Dermatol; 1990 Nov; 23(5 Pt 1):954. PubMed ID: 2254493
    [No Abstract]   [Full Text] [Related]  

  • 2. Vehicle design for a new topical steroid, fluocinonide.
    Ostrenga J; Haleblian J; Poulsen B; Ferrell B; Mueller N; Shastri S
    J Invest Dermatol; 1971 May; 56(5):392-9. PubMed ID: 5556528
    [No Abstract]   [Full Text] [Related]  

  • 3. [Telethermography, a new method in the evaluation of topical corticosteroid activity].
    Ippolito F; Di Carlo A
    G Ital Dermatol Venereol; 1988 Jun; 123(6):291-5. PubMed ID: 3215671
    [No Abstract]   [Full Text] [Related]  

  • 4. [Atrophic changes in the skin from the use of corticosteroid ointments].
    Somov BA; Markin IIa
    Sov Med; 1973 Apr; 36(4):137-8. PubMed ID: 4769996
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the activity of topical pharmaceuticals having a corticosteroid base].
    Gillet-Vanderbruggen M
    J Pharm Belg; 1973; 28(5):515-44. PubMed ID: 4585719
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ranking of corticosteroid ointments - an updating].
    Agrup G; Lassus A; Lidén S; Osmundsen PE; Rajka G; Søndergaard J
    Nord Med; 1983; 98(12):294-5. PubMed ID: 6657473
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative bio-availability and activity of proprietary topical corticosteroid preparations: vasoconstrictor assays on thirty-one ointments.
    Barry BW; Woodford R
    Br J Dermatol; 1975 Nov; 93(5):563-71. PubMed ID: 1203181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proprietary hydrocortisone creams. Vasoconstrictor activities and bio-availabilities of six preparations.
    Barry BW; Woodford R
    Br J Dermatol; 1976 Oct; 95(4):423-5. PubMed ID: 974028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro release from corticosteroid ointments.
    Shah VP; Elkins JS
    J Pharm Sci; 1995 Sep; 84(9):1139-40. PubMed ID: 8537896
    [No Abstract]   [Full Text] [Related]  

  • 10. The treatment of mild pemphigus vulgaris and pemphigus foliaceus with a topical corticosteroid.
    Dumas V; Roujeau JC; Wolkenstein P; Revuz J; Cosnes A
    Br J Dermatol; 1999 Jun; 140(6):1127-9. PubMed ID: 10354082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The same glucocorticoid in brand-name products. Does increasing the concentration result in greater topical biologic activity?
    Stoughton RB; Wullich K
    Arch Dermatol; 1989 Nov; 125(11):1509-11. PubMed ID: 2817915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dilution of proprietary corticosteroid ointments--an attempt to evaluate relative clinical potencies.
    Gibson JR; Darley C; Kirsch J; Saihan EM; Neild VS
    Br J Dermatol; 1982 Apr; 106(4):445-7. PubMed ID: 7073968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical corticosteroid compounding: effects on physicochemical stability and skin penetration rate.
    Krochmal L; Wang JC; Patel B; Rodgers J
    J Am Acad Dermatol; 1989 Nov; 21(5 Pt 1):979-84. PubMed ID: 2808834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical corticosteroid-induced skin blanching measurement: eye or instrument?
    Haigh JM; Smith EW
    Arch Dermatol; 1991 Jul; 127(7):1065. PubMed ID: 1898473
    [No Abstract]   [Full Text] [Related]  

  • 15. Dwarfism following long-term topical corticosteroid therapy.
    Bode HH
    JAMA; 1980 Aug 22-29; 244(8):813-4. PubMed ID: 7392193
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of corticosteroids on human epidermal mitotic activity.
    Fisher LB; Maibach HI
    Arch Dermatol; 1971 Jan; 103(1):39-44. PubMed ID: 4321801
    [No Abstract]   [Full Text] [Related]  

  • 17. [The external treatment of dermatoses (author's transl)].
    Ormea F
    MMW Munch Med Wochenschr; 1974 Mar; 116(13):637-42. PubMed ID: 4212846
    [No Abstract]   [Full Text] [Related]  

  • 18. [The particle size of dexamethasone incorporated in ointments and its relation to the penetration of emulsion ointments into the horny layer of the skin in vivo].
    Kleine-Natrop HE
    Rev Med Chir Soc Med Nat Iasi; 1976; 80(3):425-31. PubMed ID: 1024238
    [No Abstract]   [Full Text] [Related]  

  • 19. Development and evaluation of ointment and cream vehicles for a new topical steroid, fluclorolone acetonide.
    Malone T; Haleblian JK; Poulsen BJ; Burdick KH
    Br J Dermatol; 1974 Feb; 90(2):187-95. PubMed ID: 4819137
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and new.
    Kerscher MJ; Hart H; Korting HC; Stalleicken D
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):187-9. PubMed ID: 7620686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.